July 29- Impax Laboratories Inc said the U.S. Food and Drug Administration issued certain observations regarding violations in the company's manufacturing plant in Taiwan. Shares of Impax, which makes generics and specialty drugs to treat central nervous system disorders, fell about 17 percent to $23.15 premarket on Tuesday.» Read More
Republicans blocked a bill that was designed to override a Supreme Court ruling and ensure access to contraception for women who get their health insurance from companies with religious objections. But Democrats hope the issue has enough life to energize female voters in the fall, when Republicans are threatening to take control of the Senate.
DAPU, China, July 16- After a test showed farmer Zhao Heping's toddler grandson had high levels of lead in his blood two years ago, local officials in China's Hunan province offered the child medicine, he says- and milk.
CNBC's Meg Tirrell reports which biotech companies are working on what analysts say could be the next big biotech catalyst known as NASH, or nonalcoholic steatohepatitis.
Hundreds have died in West Africa from the Ebola virus. With no known cure and a high mortality rate, alarm is real.
Most millennials use alternative medicine to maintain wellbeing rather than cure existing sicknesses. The Fiscal Times reports.
July 15- Johnson& Johnson reported higher-than-expected quarterly revenue and earnings, benefiting from strong sales of its Olysio treatment for hepatitis C. Sales jumped 9.1 percent to $19.5 billion, beating Wall Street expectations of $18.99 billion.
CONAKRY, Guinea/ KENEMA, Sierra Leone, July 13- G overnments and health agencies trying to contain the world's deadliest ever Ebola epidemic in West Africa fear the contagion could be worse than reported because suspicious locals are chasing away health workers and shunning treatment.
CNBC's Meg Tirrell reports there are currently 67 medicines in development for Alzheimer's, with the biggest players in the space including Eli Lilly, Roche/Genentech and Biogen.
July 11- Two members of the U.S. Senate Finance Committee, including Chairman Ron Wyden, on Friday asked Gilead Sciences Inc to defend the more than $80,000 cost of its breakthrough treatment for hepatitis C, citing the expense to federal healthcare programs.
July 11- Two members of the U.S. Senate Finance Committee, including Chairman Ron Wyden, on Friday asked Gilead Sciences Inc to defend the more than $80,000 cost of its breakthrough new treatment for hepatitis C, citing the expense to federal healthcare programs.
PARIS, July 11- The first vaccine against dengue fever, from France's Sanofi, provided moderate protection in a large clinical study, but questions remain as to how well it can help fight the world's fastest-growing tropical disease.
In a continuing effort to cut costs and make medical care more convenient, insurers and employers are starting to embrace telemedicine - seeing a doctor online. Bertha Coombs looks at how telemedicine works, and how widespread the practice could become.
Former Governor Gary Johnson, (R-N.M.), discusses the medical marijuana movement, and his high hopes for expanding the pot industry. Johnson also explains the medical benefits of oil-based cannabis.
July 9- Celgene Corp said a drug being tested to treat a type of arthritis that affects the spine failed to meet the main goal in a late-stage trial, sending the company's shares down 3 percent premarket. Celgene said it would continue the study unchanged based on a recommendation by an independent data monitoring committee.
NEW YORK, July 8- That obesity can cut life short by causing strokes and other illnesses comes as no surprise, but a study reported on Tuesday quantifies the toll: The most extreme cases cut a person's lifespan more than cigarettes. The analysis, published in the journal PLOS Medicine, is the largest-ever study of the effect of extreme obesity on mortality.
July 8- Anacor Pharmaceutical Inc said the U.S. Food and Drug Administration approved its treatment for a fungal infection of the toenail. The topical solution, Kerydin, is expected to be launched as early as the end of the quarter in the United States, the company said on Tuesday.
Bob Leeds, Sea of Green Farms, is a licensed marijuana grower in the state of Washington. Leeds discusses his upstart progression and says he has invested about $2 million in the process to date.
Teresa Yuan, King TV, reports from one of the first legal marijuana shops in the state of Washington.
In preparatory documents posted on the agency's website on Tuesday, FDA reviewers said laparoscopic power morcellator devices, which are used to treat uterine fibroids, allow for less invasive surgeries, shorter recovery time and fewer wound site infections.
July 8- German drugmaker Boehringer Ingelheim said its experimental blood cancer drug met its main goal in a mid-stage trial and improved overall survival rate among patients.